ArticleBMC public health2025
Innovation through telemedicine to improve medication abortion access in primary health centers: findings from a pilot study in Musanze District, Rwanda.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transforming reproductive healthcare delivery through telemedicine services expansion: evidence from a mixed-methods pilot evaluation in rural Ghana.BMJ global health · 2026Article
- The Non-Legal Barriers Experienced Among Adolescent Girls and Young Women in Selected Districts of Rwanda Seeking Safe Abortion Services.International journal of women's health · 2026Article
- Telehealth for all: Rwanda's digital leap in sexual and reproductive healthcare access.Sexual and reproductive health matters · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In 2012 Rwanda expanded legal grounds for abortion to include cases of rape, incest, forced marriage, the health of a pregnant person or fetus at risk, and for minors on request in 2018. The penal code limits abortion care to doctors in hospitals, impeding access for many women. We tested an intervention that provides first-trimester medication abortion at primary health centers, using telemedicine to connect nurses/midwives to doctors in district hospitals for authorization of services. We implemented a 15-month prospective study to assess the feasibility, effectiveness, safety, and client acceptability of a hybrid telemedicine model. In the model tested, doctors provided clinical guidance by reviewing client data and lab results, and authorized the procedure via telemedicine, while the nurses/midwives consulted with the client, provided medication at the health center, and conducted follow-up over the phone or in person. Service data record forms were completed using the REDCap online platform and client exit interviews were conducted after completion of the abortion. During implementation, 242 clients received medication abortion at the health centers, with 50% of clients interviewed during client exit interviews. The protocol ensured high adherence rates; 96% completed abortion. Post-procedure complications were rare (3%) and were largely managed at health centers with remote support from a medical doctor. Vaginal bleeding (36%) and abdominal pain (41%) were the prevalent side effects experienced by clients; only 10% of clients who reported side effects needed to see a provider for management. Overall client satisfaction with services was very high (98%) and the perceived quality of services was also very high (97-99%). We conclude that this hybrid telemedicine model for the provision of first-trimester medication abortion is feasible, effective, safe and accepted by clients. Results from this study will enable revisions to the abortion clinical guidelines to include task-sharing with mid-level providers, such as nurses and midwives, via telemedicine in health centers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.